ENTX · Entera Bio Ltd.
$3.23
-0.70 (-17.73%)
At close · Jul 28
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's current capital resources do not include the capital required to fully fund the Company's proposed Phase 3 program for EB613 in osteoporosis. These factors raise substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed May 8, 2026
Market Cap
$160.47M
Shares
49.23M
Entera Bio Ltd. Earnings Call Transcripts
Every quarterly earnings call for Entera Bio Ltd. (ENTX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY25 · Q4
2026-04-20
Entera Bio Ltd. Q4 FY2025 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q1
2022-05-12
Entera Bio Ltd. Q1 FY2022 Earnings Call
Revenue
$68,000
▼ 56.7% YoY Diluted EPS
$0.13
Gross margin
20.6%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
Entera Bio Ltd. Q4 FY2021 Earnings Call
Revenue
$165,000*
Gross margin
17.6%
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–3 of 3 earnings calls